
ZYBT P/E Ratio
P/E Ratio as of Jun 13, 2025: 106.55
Average128.76
Median131.00
Minimum86.72
Maximum163.53
106.55
Past Month-21.52 (16.80%)
The P/E ratio for ZYBT is 106.55 as of Jun 13, 2025. This represents a increase of 97.50% compared to its 12-month average P/E ratio of 53.95. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Zhengye Biotechnology Holding Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Zhengye Biotechnology Holding Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Zhengye Biotechnology Holding Ltd to industry peers.
Zhengye Biotechnology Holding Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Zhengye Biotechnology Holding Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Zhengye Biotechnology Holding Ltd to industry peers.
ZYBT P/E Ratio Insights
See Zhengye Biotechnology Holding Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ZYBT
Order type
Buy in
Order amount
Est. shares
0 shares
ZYBT P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $9.16 | 153.95 |
May 1, 2025 | $10.43 | 175.29 |
Apr 1, 2025 | $5.32 | 89.41 |
Mar 3, 2025 | $4.43 | 74.45 |
Feb 3, 2025 | $4.32 | 72.61 |
Jan 7, 2025 | $4.86 | 81.68 |
ZYBT End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 106.55 | — |
FAQs About Zhengye Biotechnology Holding Ltd (ZYBT) P/E ratio
The latest P/E ratio of ZYBT is 106.55, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Zhengye Biotechnology Holding Ltd’s last 12-month average P/E ratio is 53.95, compared to its current P/E ratio of 106.55. This reflects a increase of 97.50%.
Zhengye Biotechnology Holding Ltd’s current P/E ratio of 106.55 is higher than its last 12-month average P/E of 53.95. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Zhengye Biotechnology Holding Ltd’s average P/E ratio over the last 3 years is 17.98. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Zhengye Biotechnology Holding Ltd’s average P/E ratio over the last 5 years is 10.79. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.